Robert Stanislaro

Robert Stanislaro is a Senior Managing Director, co-leads the Life Sciences subsector, and is Head of the Healthcare & Life Sciences’ Corporate Reputation offering within the Strategic Communications segment at FTI Consulting. He is based in New York.

Mr. Stanislaro’s diverse experience working with healthcare and life sciences companies, and unique combination of scientific and business knowledge enables him to counsel his clients on a variety of issues, which play a critical role in driving enterprise value. He has a particular expertise in corporate communications, capital markets communications and issues management, and is a strategic advisor to several C-level executives in the biotechnology and pharmaceutical industries.

Throughout his career, Mr. Stanislaro has developed multi-stakeholder communications programs for leading healthcare and life sciences companies and medical societies including Pfizer, Takeda, Moderna, bluebird bio, Shire, Eli Lilly, Astellas, GE Healthcare, Smith & Nephew, and the American Society of Anesthesiologists. These programs have focused on positioning his clients as thought leaders in their respective industries, communicating through strategic transition periods, and supporting a number of inflection points including clinical trial results, product approvals and divestitures, financings, collaborations, mergers and acquisitions, peer-reviewed research and management changes. Mr. Stanislaro also has considerable experience working with emerging biotechnology companies and research organizations, such as ImmunoGen, Walden Biosciences, Evelo, TESARO, Karyopharm, Kiniksa, Quintiles and Duke Clinical Research Institute.

Mr. Stanislaro holds an M.B.A. in marketing from Baruch College’s Zicklin School of Business and a B.S. in biology from Wagner College.